Is a complete ACH research report available?

No complete published report is available for Accendra Health, Inc. (ACH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Accendra Health, Inc. (ACH)

NYSE: ACH · USD

$0.23

+0.03 (+12.9%)· Recorded snapshot

Market cap	17.6M
Revenue (ttm)	2.6B
Net income (ttm)	-302.1M
EPS (ttm)	-$3.95
Shares out	76.9M
Volume	1,112,988
Beta	1.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.6B
Net income (ttm): -302.1M
EPS (ttm): -$3.95
Market cap: 17.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ถือ

Metric	Value
Amount currency	USD
CIK code	0000075252
Company name	Accendra Health, Inc.
Country	United States
Country code	US
CUSIP number	690732102
Earnings date	2026-11-05
Earnings time	amc
Employees	6,500
Employees change	-16,700
Employees growth	-71.98%
Enterprise value	$1.8B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1882
In index	RUSSELL2000
Industry	Medical Distribution
Is primary listing	Yes
Is SPAC	No
ISIN number	US6907321029
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split date	2010-04-01
Last stock split type	Forward
Market cap	$17.6M
Market cap category	Nano-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$0.23
Price currency	USD
Sector	Healthcare
Stock price date	2026-10-28
Symbol	ACH
U.S. state	Virginia
Website	https://www.accendrahealth.com

Metric

Value

Amount currency

USD

CIK code

0000075252

Company name

Accendra Health, Inc.

Country

United States

Country code

CUSIP number

690732102

Earnings date

2026-11-05

Earnings time

amc

Employees

6,500

Employees change

-16,700

Employees growth

-71.98%

Enterprise value

$1.8B

Exchange

NYSE

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1882

In index

RUSSELL2000

Industry

Medical Distribution

Is primary listing

Yes

Is SPAC

ISIN number

US6907321029

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split date

2010-04-01

Last stock split type

Forward

Market cap

$17.6M

Market cap category

Nano-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$0.23

Price currency

USD

Sector

Healthcare

Stock price date

2026-10-28

Symbol

ACH

U.S. state

Virginia

Website

https://www.accendrahealth.com

Metric	Value
Adjusted P/E ratio	1x
Earnings yield	-1,720%
EV/EBIT	56.87x
EV/EBITDA	6.34x
EV/Sales	0.69x
FCF / EV yield	-19.53%
FCF yield	-2,147.28%
Forward EV/Sales	0.73x
Forward P/S	0.01x
Industry forward P/E	19.16x
Industry P/E	27.41x
P/S ratio	0.01x
Price/EBITDA ratio	0.06x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

Earnings yield

-1,720%

EV/EBIT

56.87x

EV/EBITDA

6.34x

EV/Sales

0.69x

FCF / EV yield

-19.53%

FCF yield

-2,147.28%

Forward EV/Sales

0.73x

Forward P/S

0.01x

Industry forward P/E

19.16x

Industry P/E

27.41x

P/S ratio

0.01x

Price/EBITDA ratio

0.06x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	1.21%
EBITDA margin	10.89%
Gross margin	44.83%
Operating margin	1.21%
Pretax margin	-4.36%
Profit margin	-11.41%
Profit per employee	$-46,483
Revenue per employee	$407,268
ROA	0.64%
ROA (5Y)	3.56%
ROCE	2.23%
ROE (5Y)	-36.01%
ROIC	2.42%
ROIC (5Y)	8.46%
SBC / revenue	0.4%
Tax / revenue	-0.18%

Metric

Value

EBIT margin

1.21%

EBITDA margin

10.89%

Gross margin

44.83%

Operating margin

1.21%

Pretax margin

-4.36%

Profit margin

-11.41%

Profit per employee

$-46,483

Revenue per employee

$407,268

ROA

0.64%

ROA (5Y)

3.56%

ROCE

2.23%

ROE (5Y)

-36.01%

ROIC

2.42%

ROIC (5Y)

8.46%

SBC / revenue

0.4%

Tax / revenue

-0.18%

Metric	Value
EPS growth quarters	3
EPS growth years	0
Gross profit growth	-9.3%
Gross profit growth (Q)	-18.85%
Gross profit growth 3Y	-15.07%
Gross profit growth 5Y	-5.63%
Net income growth quarters	3
Net income growth years	0
Operating income growth	-84.2%
Operating income growth 3Y	-28.11%
Operating income growth 5Y	-41.08%
Revenue growth	-3.3%
Revenue growth (Q)	-10.07%
Revenue growth (QoQ)	-2.32%
Revenue growth 10Y	-12.36%
Revenue growth 3Y	-36.08%
Revenue growth 5Y	-22.33%
Revenue growth years	2

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-9.3%

Gross profit growth (Q)

-18.85%

Gross profit growth 3Y

-15.07%

Gross profit growth 5Y

-5.63%

Net income growth quarters

Net income growth years

Operating income growth

-84.2%

Operating income growth 3Y

-28.11%

Operating income growth 5Y

-41.08%

Revenue growth

-3.3%

Revenue growth (Q)

-10.07%

Revenue growth (QoQ)

-2.32%

Revenue growth 10Y

-12.36%

Revenue growth 3Y

-36.08%

Revenue growth 5Y

-22.33%

Revenue growth years

Metric	Value
Capital expenditures	$-176.8M
Depreciation and amortization	$256.1M
EBIT	$32.2M
EBITDA	$288.2M
EPS	$-3.95
FCF per share	$-4.64
Financing cash flow	$-157.3M
Free cash flow	$-357.2M
Free cash flow minus SBC	$-367.9M
Gross profit	$1.2B
Income taxes	$-4.9M
Investing cash flow	$268.2M
Net borrowing	$-135M
Net cash flow	$-69.4M
Net income	$-302.1M
Operating cash flow minus SBC	$-191.1M
Operating income	$32.2M
Revenue	$2.6B
Stock-based compensation	$10.7M

Metric

Value

Capital expenditures

$-176.8M

Depreciation and amortization

$256.1M

EBIT

$32.2M

EBITDA

$288.2M

EPS

$-3.95

FCF per share

$-4.64

Financing cash flow

$-157.3M

Free cash flow

$-357.2M

Free cash flow minus SBC

$-367.9M

Gross profit

$1.2B

Income taxes

$-4.9M

Investing cash flow

$268.2M

Net borrowing

$-135M

Net cash flow

$-69.4M

Net income

$-302.1M

Operating cash flow minus SBC

$-191.1M

Operating income

$32.2M

Revenue

$2.6B

Stock-based compensation

$10.7M

Metric	Value
Altman Z-Score	0.37
Book value per share	$-7.16
Debt / EBITDA	4.89
Goodwill	$1.2B
Interest coverage	0.29
Long-term assets	$1.8B
Long-term liabilities	$2B
Net cash (debt)	$-1.8B
Net cash / market cap	-10,893.3%
Net debt / EBITDA	6.29
Piotroski F-Score	3
Property, plant and equipment	$305.7M
Shareholders' equity	$-550.9M
Tangible book value	$-1.9B
Tangible book value per share	$-24.15
Total assets	$2.1B
Total cash	$7.7M
Total debt	$1.8B
Total liabilities	$2.7B
WACC	4.93%

Metric

Value

Altman Z-Score

0.37

Book value per share

$-7.16

Debt / EBITDA

4.89

Goodwill

$1.2B

Interest coverage

0.29

Long-term assets

$1.8B

Long-term liabilities

$2B

Net cash (debt)

$-1.8B

Net cash / market cap

-10,893.3%

Net debt / EBITDA

6.29

Piotroski F-Score

Property, plant and equipment

$305.7M

Shareholders' equity

$-550.9M

Tangible book value

$-1.9B

Tangible book value per share

$-24.15

Total assets

$2.1B

Total cash

$7.7M

Total debt

$1.8B

Total liabilities

$2.7B

WACC

4.93%

Metric	Value
Asset turnover	0.85
Current assets	$271.4M
Current liabilities	$666.2M
Current ratio	0.41
Inventory turnover	20.49
Net working capital	$-364M
Quick ratio	0.19
Working capital	$-394.8M
Working capital turnover	-6.87

Metric

Value

Asset turnover

0.85

Current assets

$271.4M

Current liabilities

$666.2M

Current ratio

0.41

Inventory turnover

20.49

Net working capital

$-364M

Quick ratio

0.19

Working capital

$-394.8M

Working capital turnover

-6.87

Metric	Value
Buyback yield / dilution	0.47%
Dividend growth (10Y)	-35.48%
Dividend growth (3Y)	-77.3%
Dividend growth (5Y)	-60.35%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$0.00
Shareholder yield	0.47%

Metric

Value

Buyback yield / dilution

0.47%

Dividend growth (10Y)

-35.48%

Dividend growth (3Y)

-77.3%

Dividend growth (5Y)

-60.35%

Dividend per share

$0.00

Dividend yield

Last dividend

$0.00

Shareholder yield

0.47%

Metric	Value
10Y price change	-99.31%
10Y return CAGR	-38.57%
10Y total return	-99.23%
150-day SMA	$2.24
15Y price change	-99.27%
15Y return CAGR	-26.73%
15Y total return	-99.06%
1D price change	12.95%
1M price change	-68.56%
1M total return	-68.56%
1W price change	-12.84%
1W total return	-12.84%
1Y price change	-95.94%
1Y return CAGR	-95.95%
1Y total return	-95.94%
20-day SMA	$0.33
200-day SMA	$2.26
20Y price change	-98.97%
20Y return CAGR	-19.01%
20Y total return	-98.52%
3M price change	-93.09%
3M total return	-93.09%
3Y price change	-98.4%
3Y return CAGR	-74.77%
3Y total return	-98.4%
50-day SMA	$0.75
50-day SMA vs 200-day SMA	50under200
52-week high	$5.52
52-week high date	2025-10-28
52-week low	$0.19
52-week low date	2026-10-23
5Y price change	-99.36%
5Y return CAGR	-63.63%
5Y total return	-99.36%
6M price change	-93.49%
6M total return	-93.49%
All-time high	$49.16
All-time high date	2021-06-09
All-time low	$0.19
All-time low date	2026-10-23
Average true range (ATR)	$0.06
Average volume	2.2M
Beta (1Y)	2.45
Beta (2Y)	1.4
Beta (5Y)	1.57
Change from 52-week high	-95.84%
Change from 52-week low	20.11%
Change from all-time high	-99.55%
Change from all-time low	16.54%
Change from open	6.65%
Day's gap	5.91%
Dollar volume	$255,319
High price	$0.23
Low price	$0.21
Monthly RSI	30.39
Open price	$0.22
Position in 52-week range	93.27%
Premarket change	3.35%
Premarket close	$0.20
Premarket price	$0.21
Premarket volume	7.1K
Previous close	$0.20
Price vs 150-day SMA	-90.07%
Price vs 20-day SMA	-32.44%
Price vs 200-day SMA	-90.15%
Price vs 50-day SMA	-70.42%
Relative volume	0.51
RSI	19.89
Sharpe ratio	-2.44
Sharpe ratio (3Y)	-1.17
Sharpe ratio (5Y)	-0.92
Sortino ratio	-2.79
Sortino ratio (3Y)	-1.43
Sortino ratio (5Y)	-1.14
Volume	1.1M
Weekly RSI	24.77
YTD price change	-92.05%
YTD total return	-92.05%

Metric

Value

10Y price change

-99.31%

10Y return CAGR

-38.57%

10Y total return

-99.23%

150-day SMA

$2.24

15Y price change

-99.27%

15Y return CAGR

-26.73%

15Y total return

-99.06%

1D price change

12.95%

1M price change

-68.56%

1M total return

-68.56%

1W price change

-12.84%

1W total return

-12.84%

1Y price change

-95.94%

1Y return CAGR

-95.95%

1Y total return

-95.94%

20-day SMA

$0.33

200-day SMA

$2.26

20Y price change

-98.97%

20Y return CAGR

-19.01%

20Y total return

-98.52%

3M price change

-93.09%

3M total return

-93.09%

3Y price change

-98.4%

3Y return CAGR

-74.77%

3Y total return

-98.4%

50-day SMA

$0.75

50-day SMA vs 200-day SMA

50under200

52-week high

$5.52

52-week high date

2025-10-28

52-week low

$0.19

52-week low date

2026-10-23

5Y price change

-99.36%

5Y return CAGR

-63.63%

5Y total return

-99.36%

6M price change

-93.49%

6M total return

-93.49%

All-time high

$49.16

All-time high date

2021-06-09

All-time low

$0.19

All-time low date

2026-10-23

Average true range (ATR)

$0.06

Average volume

2.2M

Beta (1Y)

2.45

Beta (2Y)

1.4

Beta (5Y)

1.57

Change from 52-week high

-95.84%

Change from 52-week low

20.11%

Change from all-time high

-99.55%

Change from all-time low

16.54%

Change from open

6.65%

Day's gap

5.91%

Dollar volume

$255,319

High price

$0.23

Low price

$0.21

Monthly RSI

30.39

Open price

$0.22

Position in 52-week range

93.27%

Premarket change

3.35%

Premarket close

$0.20

Premarket price

$0.21

Premarket volume

7.1K

Previous close

$0.20

Price vs 150-day SMA

-90.07%

Price vs 20-day SMA

-32.44%

Price vs 200-day SMA

-90.15%

Price vs 50-day SMA

-70.42%

Relative volume

0.51

RSI

19.89

Sharpe ratio

-2.44

Sharpe ratio (3Y)

-1.17

Sharpe ratio (5Y)

-0.92

Sortino ratio

-2.79

Sortino ratio (3Y)

-1.43

Sortino ratio (5Y)

-1.14

Volume

1.1M

Weekly RSI

24.77

YTD price change

-92.05%

YTD total return

-92.05%

Metric	Value
Float	56.2M
Float percentage	73.03%
Shares change (QoQ)	0.34%
Shares change (YoY)	-0.47%
Shares held by insiders	9.79%
Shares held by institutions	79.52%
Shares outstanding	76.9M
Short % of float	15%
Short % of shares	10.95%
Short ratio	6.5 days

Metric

Value

Float

56.2M

Float percentage

73.03%

Shares change (QoQ)

0.34%

Shares change (YoY)

-0.47%

Shares held by insiders

9.79%

Shares held by institutions

79.52%

Shares outstanding

76.9M

Short % of float

15%

Short % of shares

10.95%

Short ratio

6.5 days

Accendra Health, Inc. (ACH)

Price

Financial snapshot

Fair-value bridge

Latest news · ACH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ACH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ACH

Frequently asked questions